SIM0417

unknown · Jiangsu Simcere Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SIM0417, covering 2023-05-06 to 2023-05-06. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19 [Phase 2, Phase 3]

See pricing